Lord's Mark Share Price: Hospitals ko ab dialysis ke liye Fokat mein milegi facility!

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAarav Shah|Published at:
Lord's Mark Share Price: Hospitals ko ab dialysis ke liye Fokat mein milegi facility!
Overview

Arre bhaiyo, Lord's Mark Industries ne toh kamaal kar diya! Ahmedabad ke ek hospital mein unhone apna AI wala dialysis system launch kiya hai. Aur sabse mast baat kya hai? Hospitals ko iske liye **zero upfront cost** dena padega. Yeh hai apna 'Dialysis-as-a-Service' model jisse kidney treatment sabke liye easy ho jayega.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

DaaS Model ka Jaadu!

Lord's Mark Industries ne ek naya 'Dialysis-as-a-Service' (DaaS) model shuru kiya hai, jiska naam hai Aureoon. Isse hospitals ko advance kidney care dene ke liye koi bhi bada paisa zero capital investment mein mil jayega. Matlab, hospitals ko machine kharidne ka tension nahi. Yeh AI-powered Renalyx Machine aur RenalOS platform use karta hai jo smart care aur remote monitoring mein help karta hai. Yeh model India aur bahar ke markets ke liye kaafi useful hai jahan paiso ki kami hoti hai.

Stock Bhaaga, Lekin Paisa Kahan Hai?

Company ka stock pichhle ek saal mein 107% se zyada bhaga hai, aur ab ₹669.70 ke aas paas trade kar raha hai, jiska market cap ₹67 Cr hai. Lekin yahan ek warning hai, company par ₹280 Cr ka loan hai aur TTM P/E ratio negative hai, matlab abhi company loss mein chal rahi hai. Toh ye thoda risky ho sakta hai.

'Make in India' ka Power!

Renalyx Machine India mein hi design aur CE-certified hui hai. Yeh 'Make in India' ko promote karta hai. India ka medical device market $31.85 billion (2034 tak) aur dialysis market $11.7 billion (2034 tak) hone wala hai, toh yahan bada scope hai. Lord's Mark ka target hai ki March 2027 tak 50 managed dialysis centers bana le. Aur yeh imports par dependance bhi kam karega jo India mein 70-80% hai. Machine mein AI se real-time monitoring aur alerts milte hain.

Khatre Ka Ghanta!

Par bhaiyo, sab kuch itna smooth nahi hai. Pichli baar ek deal thi jisme 50% stake ₹97 per share mein buy karne ki baat thi, par woh cancel ho gayi. Market mein bade players hain jaise Fresenius Medical Care, Baxter International, DaVita. Hospitals ko new DaaS model par lana bhi ek challenge hai. US FDA approval bhi chahiye global growth ke liye, aur uska time pata nahi. DaaS model ko run karne mein operational risks bhi hain.

Future Kya Hai?

Lord's Mark ka plan hai India mein 50 centers banaye March 2027 tak, aur machine bechna aur export karna. US FDA approval se international ambitions dikhte hain. Analyst coverage kam hai, toh stock performance company ke execution par depend karega. DaaS model ko profitable banana bada kaam hoga.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.